Official Title
Evaluation of Clinical Sample Collection Project: Spartan COVID-19
Brief Summary

This study will evaluate the efficacy of various sample collection methods for use with the Spartan COVID-19 System. It will compare the results from the Spartan COVID-19 System with results that are obtained using a predicate lab-based COVID-19 test that uses a nasopharyngeal swab sample. The goal is to determine which sample collection methods are most effective in capturing SARS-CoV-2 virus.

Detailed Description

Once the subject is recruited,two nasopharyngeal swabs using the standard method will be
taken from the patient. Additionally, two nasal swab samples will be taken using the Spartan
COVID-19 swabs with an adjusted tip. All samples will be analyzed using the Spartan COVID-19
System.

The lab-based predicate test will be taken at the same time, with results reported back to
Spartan to be compared with results obtained from the Spartan COVID-19 System.

Completed
COVID19

Device: Spartan COVID-19 System

PCR analysis of patient samples using the Spartan COVID-19 System

Eligibility Criteria

Inclusion Criteria:

- must have tested positive for COVID-19 via the existing nucleic acid testing method.

Exclusion Criteria:

-

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Canada
Locations

Humber River Hospital
North York, Ontario, Canada

The Univeristy of Ottawa Heart Institute
Ottawa, Ontario, Canada

Tara Linseman, MSc, Study Director
Spartan Bioscience Inc.

Spartan Bioscience Inc.
NCT Number
MeSH Terms
COVID-19